An aroma of complexity: How the unique genetics of aromatase (cyp19a1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4676-4681

  Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN REGULATED TRANSCRIPTION COACTIVATOR; LETROZOLE; TESTOLACTONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AROMATIZATION; BREAST CARCINOMA; BREAST HYPERTROPHY; CANCER TISSUE; CHROMOSOME 15; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CYP19A1 GENE; DRUG SUBSTITUTION; ENZYME ACTIVITY; ENZYME ANALYSIS; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENITAL TRACT TUMOR; GYNECOMASTIA; HEN; HUMAN; HYENA; HYPOGONADISM; KLINEFELTER SYNDROME; LARGE CELL CALCIFYING SERTOLI CELL TUMOR; LIVER CELL CARCINOMA; NONHUMAN; OVARIAN SEX CORD TUMOR; OVARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SERTOLI CELL TUMOR; TESTIS DISEASE; TESTIS TUMOR; UPREGULATION;

46, XX DISORDERS OF SEX DEVELOPMENT; ANIMALS; AROMATASE; BREAST NEOPLASMS; CARCINOGENESIS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GYNECOMASTIA; HUMANS; INFERTILITY, MALE; MALE; METABOLISM, INBORN ERRORS; MUTATION; TESTICULAR NEOPLASMS;

EID: 84889785968     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3990     Document Type: Review

References (73)

1. Hawass Z, Gad YZ, Ismail S, et al. Ancestry and pathology in King Tutankhamun's family. JAMA. 2010;303:638-647.
2. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med. 2007;357:1229-1237.
3. Ma NS, Geffner ME. Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr. 2008;20:465-470.
4. Wosnitzer MS, Paduch DA. Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome. Am J Med Genet C Semin Med Genet. 2013;163C:16-26.
5. Hellmann P, Christiansen P, Johannsen TH, Main KM, Duno M, Juul A. Male patients with partial androgen insensitivity syndrome: A longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia. Arch Dis Child. 2012;97:403-409.
6. Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007; 356:479-485.
7. Stratakis CA, Batista D, Sabnis G, Brodie A. Prepubertal gynaecomastia caused by medication or the aromatase excess syndrome. Clin Endocrinol (Oxf). 2004;61:779-780.
8. Deepinder F, Braunstein GD. Drug-induced gynecomastia: An evidence- based review. Expert Opin Drug Saf. 2012;11:779-795.
9. Burra P. Liver abnormalities and endocrine diseases. Best Pract Res Clin Gastroenterol. 2013;27:553-563.
10. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev. 2009;30:343-375.
11. Steinach E, Kun H. Transformation of male sex hormones into a substance with the action of a female hormone. Lancet. 1937;230: 845.
12. Meyer AS, Hayano M, Lindberg MC, Gut M, Rodgers G. The conversion of 4-androstene-3,17-dione-4-C14 and dehydroepiandrosterone by bovine adrenal homogenate preparations. Acta Endocrinol. 1955;18:148-168.
13. Ryan KJ. Biological aromatization of steroids. J Biol Chem. 1959; 234:268-272.
14. Morato T, Raab K, Brodie HJ, Hayano M, Dorfman RI. The mechanism of estrogen biosynthesis. J Am Chem Soc. 1962;84:3764- 3766.
15. Brodie HJ, Kripalani KJ, Possanza G. Studies on the mechanism of estrogen biosynthesis. VI. The stereochemistry of hydrogen elimination at C-2 during aromatization. J Am Chem Soc. 1969;91: 1241-1242.
16. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973; 36:207-214.
17. Adams JB, Li K. Biosynthesis of ß-oestradiol in human breast carcinoma tissue and a novel method for its characterization. Br J Cancer. 1975;31:429-433.
18. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ. Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab. 1983;57:1125-1128.
19. Barone RM, Shamonki IM, Siiteri PK, Judd HL. Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using 1-testololactone. J Clin Endocrinol Metab. 1979;49:672-676.
20. Mendelson CR, Wright EE, Evans CT, Porter JC, Simpson ER. Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P- 450AROM), and their use in its purification. Arch Biochem Biophys. 1985;243:480-491.
21. Evans CT, Ledesma DB, Schulz TZ, Simpson ER, Mendelson CR. Isolation and characterization of a complementaryDNAspecific for human aromatase-system cytochrome P-450 mRNA. Proc Natl Acad Sci USA. 1986;83:6387-6391.
22. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA. 1993; 90:11673-11677.
23. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 1994;78:1287-1292.
24. Mango D, Montemurro A, Scirpa P, Bompiani A, Menini E. Four cases of pregnancy with low estrogen production due to placental enzymatic deficiency. Eur J Obstet Gynecol Reprod Biol. 1978;8: 65-71.
25. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: Placental aromatase deficiency. J Clin Endocrinol Metab. 1991;72:560-566.
26. Harada N, Ogawa H, Shozu M, et al. Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J Biol Chem. 1992;267:4781-4785.
27. Bulun SE. Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab. 1996;81:867-871.
28. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Arodoimatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80:3689-3698.
29. Lin L, Ercan O, Raza J, et al. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab. 2007;92:982-990.
30. Yalcinkaya TM, Siiteri PK, Vigne JL, et al. A mechanism for virilization of female spotted hyenas in utero. Science. 1993;260:1929- 1931.
31. Place NJ, Glickman SE. Masculinization of female mammals: lessons from nature. Adv Exp Med Biol. 2004;545:243-253.
32. Leshin M, George FW, Wilson JD. Increased estrogen synthesis in the Sebright bantam is due to a mutation that causes increased aromatase activity. Trans Assoc Am Phys. 1981;94:97-105.
33. George FW, Matsumine H, McPhaul MJ, Somes RG Jr, Wilson JD. Inheritance of the henny feathering trait in the Golden Campine chicken: Evidence for allelism with the gene that causes henny feathering in the Sebright bantam. J Hered. 1990;81:107-110.
34. Ljungberg T. Hereditary gynaecomastia. Acta Medica Scandinavica. 1960;168:371-379.
35. Ferriman DG. Gynaecomastis in two brothers. Brit Med J. 1954;2: 685-686.
36. Wallach EE, Garcia CR. Familial gynecomastia without hypogonadism: A report of three cases in one family. J Clin Endocrinol Metab. 1962;22:1201-1206.
37. Eisenstodt LW. Mastectomy by mammaplasty for gynecomastia; gynecomastia in identical twins. J Int Coll Surg. 1952;18:1-14.
38. Hemsell DL, Edman CD, Marks JF, Siiteri PK, MacDonald PC. Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest. 1977; 60:455-464.
39. Berkovitz GD, Guerami A, Brown TR, MacDonald PC, Migeon CJ. Familial gynecomastia with increased extraglandular aromatization of plasma carbon 19-steroids. J Clin Invest. 1985;75:1763-1769.
40. Stratakis CA, Vottero A, Brodie A, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab. 1998;83(4):1348-1357.
41. Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S. Organization of the human aromatase P450 (CYP19) gene. Semin Reprod Med. 2004;22:5-9.
42. Mahendroo MS, Means GD, Mendelson CR, Simpson ER. Tissuespecific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J Biol Chem. 1991;266:11276-11281.
43. Means GD, KilgoreMW,Mahendroo MS, Mendelson CR, Simpson ER. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol. 1991;5:2005-2013.
44. Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA. 1993;90:11312- 11316.
45. Chen D, Reierstad S,LuM,Lin Z, Ishikawa H, Bulun SE. Regulation of breast cancer-associated aromatase promoters. Cancer Lett. 2009;273:15-27.
46. Agarwal VR, Takayama K, Van Wyk JJ, Sasano H, Simpson ER, Bulun SE. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab. 1998;83:1797-1800.
47. Bulun SE, Rosenthal IM, Brodie AM, et al. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. J Clin Endocrinol Metab. 1994; 78:1616-1621.
48. Coen P, Kulin H, Ballantine T, et al. An aromatase-producing sexcord tumor resulting in prepubertal gynecomastia. N Engl J Med. 1991;324:317-322.
49. Gourgari E, Saloustros E, Stratakis CA. Large-cell calcifying Sertoli cell tumors of the testes in pediatrics. Curr Opin Pediatr. 2012;24: 518-522.
50. Ham S, Meachem SJ, Choong CS, et al. Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz Jeghers syndrome. J Clin Endocrinol Metab. 2013;98:E1979-E1987.
51. Boardman LA, Couch FJ, Burgart LJ, et al. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat. 2000;16:23-30.
52. Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer. 2011;10:481-490.
53. Brown KA, McInnes KJ, Hunger NI, Oakhill JS, Steinberg GR, Simpson ER. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res. 2009;69:5392-5399.
54. Samarajeewa NU, Docanto MM, Simpson ER, Brown KA. CREBregulated transcription co-activator family stimulates promoter IIdriven aromatase expression in preadipocytes. Horm Cancer. 2013; 4:233-241.
55. ShozuM,Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med. 2003;348:1855-1865.
56. Tiulpakov A, Kalintchenko N, Semitcheva T, et al. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome. J Clin Endocrinol Metab. 2005;90:4184-4190.
57. Demura M, Martin RM, Shozu M, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet. 2007;16:2529-2541.
58. Bulun SE, Lin Z, Imir G, Amin S, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57:359-383.
59. Fukami M, Shozu M, Soneda S, et al. Aromatase excess syndrome: Identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants. J Clin Endocrinol Metab. 2011;96:E1035 - E1045.
60. Fukami M, Tsuchiya T, Vollbach H, et al. Genomic basis of aromatase excess syndrome: Recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression. J Clin Endocrinol Metab. 2013;98:E2013-E2021.
61. Shihara D, Miyado M, Nakabayashi K, et al. Aromatase excess syndrome in a family with upstream deletion of CYP19A1 [published online ahead of print September 18, 2013]. Clin Endocrinol (Oxf). doi:10.1111/cen.12329.
62. Liu P, Carvalho CM, Hastings PJ, Lupski Jr. Mechanisms for recurrent and complex human genomic rearrangements. Curr Opin Genet Dev. 2012;22:211-220.
63. Stankiewicz P, Lupski Jr. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437-455.
64. Fukami M, Suzuki J, Nakabayashi K, et al. Lack of genomic rearrangements involving the aromatase geneCYP19A1in breast cancer [published online ahead of print April 30, 2013]. Breast Cancer. doi:10.1007/s12282-013-0471-5.
65. Stratakis CA, Lafferty A, Taymans SE, Gafni RI,MeckJM, Blancato J. Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419- D16S503). J Clin Endocrinol Metab. 2000;85:3396-3401.
66. van den Berg L, de Waal HD, Han JC, et al. Investigation of a patient with a partial trisomy 16q including the fat mass and obesity associated gene (FTO): fine mapping and FTO gene expression study. Am J Med Genet A. 2010;152A:630-637.
67. Li X, Strauss L, Mäkelä S, et al. Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am J Pathol. 2004;164:1039-1048.
68. Mauras N, Bishop K, Merinbaum D, Emeribe U, Agbo F, Lowe E. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia. J Clin Endocrinol Metab. 2009;94:2975-2978.
69. Binder G, Iliev DI, Dufke A, et al. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. J Clin Endocrinol Metab. 2005;90:484-492.
70. Winterfield L, Schultz J, Stratakis CA, Cowen EW. Gynecomastia and mucosal lentigines in an 8-year-old boy. J Am Acad Dermatol. 2005;53:660-662.
71. Lefevre H, Bouvattier C, Lahlou N, Adamsbaum C, Bougnères P, Carel JC. Prepubertal gynecomastia in Peutz-Jeghers syndrome: Incomplete penetrance in a familial case and management with an aromatase inhibitor. Eur J Endocrinol. 2006;154:221-227.
72. Grandone A, del Giudice EM, Cirillo G, Santarpia M, Coppola F, Perrone L. Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: Two years' treatment with anastrozole and genetic study. Horm Res Paediatr. 2011;75:374-379.
73. Boone PM, Soens ZT, Campbell IM, et al. Incidental copy-number variants identified by routine genome testing in a clinical population. Genet Med. 2013;15:45-54.